Pale Fire Capital SE’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,897
| Closed | -$143K | – | 66 |
|
|
2025
Q1 | $143K | Buy |
42,897
+4,022
| +10% | +$13.4K | 0.02% | 45 |
|
|
2024
Q4 | $288K | Buy |
38,875
+1,500
| +4% | +$11.1K | 0.07% | 26 |
|
|
2024
Q3 | $351K | Buy |
37,375
+22,675
| +154% | +$213K | 0.06% | 31 |
|
|
2024
Q2 | $118K | Buy |
14,700
+3,700
| +34% | +$29.7K | 0.01% | 34 |
|
|
2024
Q1 | $163K | Sell |
11,000
-6,024
| -35% | -$89.3K | 0.02% | 38 |
|
|
2023
Q4 | $138K | Buy |
17,024
+1,924
| +13% | +$15.6K | 0.02% | 56 |
|
|
2023
Q3 | $68.7K | Buy |
+15,100
| New | +$68.7K | 0.01% | 62 |
|